INKT
Price
$13.97
Change
+$0.36 (+2.65%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
61.56M
PHVS
Price
$24.17
Change
-$0.41 (-1.67%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
1.58B
40 days until earnings call
Interact to see
Advertisement

INKT vs PHVS

Header iconINKT vs PHVS Comparison
Open Charts INKT vs PHVSBanner chart's image
MiNK Therapeutics
Price$13.97
Change+$0.36 (+2.65%)
Volume$300
Capitalization61.56M
Pharvaris
Price$24.17
Change-$0.41 (-1.67%)
Volume$804
Capitalization1.58B
INKT vs PHVS Comparison Chart in %
Loading...
INKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INKT vs. PHVS commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INKT is a Buy and PHVS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (INKT: $13.61 vs. PHVS: $24.58)
Brand notoriety: INKT and PHVS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INKT: 45% vs. PHVS: 68%
Market capitalization -- INKT: $61.56M vs. PHVS: $1.58B
INKT [@Biotechnology] is valued at $61.56M. PHVS’s [@Biotechnology] market capitalization is $1.58B. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INKT’s FA Score shows that 0 FA rating(s) are green whilePHVS’s FA Score has 0 green FA rating(s).

  • INKT’s FA Score: 0 green, 5 red.
  • PHVS’s FA Score: 0 green, 5 red.
According to our system of comparison, both INKT and PHVS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INKT’s TA Score shows that 2 TA indicator(s) are bullish while PHVS’s TA Score has 4 bullish TA indicator(s).

  • INKT’s TA Score: 2 bullish, 6 bearish.
  • PHVS’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, PHVS is a better buy in the short-term than INKT.

Price Growth

INKT (@Biotechnology) experienced а -11.34% price change this week, while PHVS (@Biotechnology) price change was +0.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.17%. For the same industry, the average monthly price growth was +9.43%, and the average quarterly price growth was +55.19%.

Reported Earning Dates

PHVS is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+4.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHVS($1.58B) has a higher market cap than INKT($61.6M). INKT YTD gains are higher at: 95.293 vs. PHVS (26.082). INKT has higher annual earnings (EBITDA): -9.92M vs. PHVS (-165.21M). PHVS has more cash in the bank: 200M vs. INKT (1.68M). PHVS has less debt than INKT: PHVS (634K) vs INKT (5.51M). INKT (0) and PHVS (0) have equivalent revenues.
INKTPHVSINKT / PHVS
Capitalization61.6M1.58B4%
EBITDA-9.92M-165.21M6%
Gain YTD95.29326.082365%
P/E RatioN/AN/A-
Revenue00-
Total Cash1.68M200M1%
Total Debt5.51M634K868%
TECHNICAL ANALYSIS
Technical Analysis
INKTPHVS
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 19 days ago
81%
Bullish Trend 8 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 3 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
INKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PMPRX15.85N/A
N/A
Principal MidCap Value I R3
ACESX11.31N/A
N/A
Invesco Equity and Income R
DDDRX15.92N/A
N/A
Macquarie Wealth Builder R
FSBCX21.54N/A
N/A
Federated Hermes Global Allocation C
IICHX12.23N/A
N/A
AMF Large Cap Equity H

INKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, INKT has been loosely correlated with RAIN. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if INKT jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INKT
1D Price
Change %
INKT100%
-5.09%
RAIN - INKT
44%
Loosely correlated
+6.12%
LPTX - INKT
42%
Loosely correlated
+12.63%
DARE - INKT
36%
Loosely correlated
-2.80%
PHVS - INKT
36%
Loosely correlated
+0.66%
SONN - INKT
36%
Loosely correlated
-14.17%
More

PHVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHVS has been loosely correlated with INKT. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if PHVS jumps, then INKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHVS
1D Price
Change %
PHVS100%
-1.67%
INKT - PHVS
36%
Loosely correlated
+2.65%
HOWL - PHVS
34%
Loosely correlated
+1.98%
CELC - PHVS
30%
Poorly correlated
-2.58%
SNDX - PHVS
30%
Poorly correlated
+4.29%
MGTX - PHVS
29%
Poorly correlated
-0.06%
More